Outsourcing

Videos

Bob Hughes (Research Fellow, Grace) and Brian Graves (Global Business Manager, Fine Chemicals, Grace) explain how Grace's experience as a CDMO can help customers from the lab to full-scale production. 

Grace: Your API CDMO Partner of Choice

Articles

Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.

It’s All About the Small Things

Feliza Mirasol is the science editor for 

Rentschler Biopharma has expanded its service offerings at its Stevenage, UK, site with a new lentiviral vector manufacturing toolbox.

Rentschler Biopharma Offers New Toolbox for LV Manufacturing

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Vernal Biosciences’ CEO and founder, Christian Cobaugh, discusses the outsourcing landscape for mRNA production.

A Discussion on the Outsourcing of mRNA Production (BIO  2024)

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services. 

Agilent Expands Biopharma Offerings with BIOVECTRA Acquisition

PluriCDMO, Pluri's newly launched CDMO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.

Kadimastem and Pluri Enter Cell Therapy Manufacturing Deal

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

This collaboration aims to support and accelerate clinical development of advanced and novel technologies.

Aurigene to Provide Cell Therapy Discovery Services to Edity to Support Clinical Development

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

 Flexibility in Outsourcing Models (BIO 2024)

Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.

Sterling Invests in Expansion of Integrated ADC Services

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product. 

Contract Manufacturing Services